Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Congress approves global AIDS plan

Executive Summary

The Senate votes 80-16 to renew the President's Emergency Plan for AIDS Relief in July, following support from the House earlier this year. Members agree to expand PEPFAR funds to $50 billion for the 2009-2013 fiscal years to support AIDS research and treatment efforts - a significant increase from its current $15 billion cap. One provision agreed to in the Senate would withhold 20 percent of the appropriations for the Global AIDS Fund until the State Department confirms access to financial data to monitor the use of such monies. The bill would also allocate money to fight tuberculosis and malaria (1"The Pink Sheet," April 7, 2008, In Brief)

Latest Headlines
See All
UsernamePublicRestriction

Register

PS049910

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel